136 related articles for article (PubMed ID: 18491534)
1. Technical note: dose-volume histogram analysis in radiotherapy using the Gaussian error function.
Chow JC; Markel D; Jiang R
Med Phys; 2008 Apr; 35(4):1398-402. PubMed ID: 18491534
[TBL] [Abstract][Full Text] [Related]
2. The effect of interfraction prostate motion on IMRT plans: a dose-volume histogram analysis using a Gaussian error function model.
Chow JCL; Jiang R; Markel D
J Appl Clin Med Phys; 2009 Sep; 10(4):79-95. PubMed ID: 19918231
[TBL] [Abstract][Full Text] [Related]
3. The use of spatial dose gradients and probability density function to evaluate the effect of internal organ motion for prostate IMRT treatment planning.
Jiang R; Barnett RB; Chow JC; Chen JZ
Phys Med Biol; 2007 Mar; 52(5):1469-84. PubMed ID: 17301465
[TBL] [Abstract][Full Text] [Related]
4. Quantifying the effect of intrafraction motion during breast IMRT planning and dose delivery.
George R; Keall PJ; Kini VR; Vedam SS; Siebers JV; Wu Q; Lauterbach MH; Arthur DW; Mohan R
Med Phys; 2003 Apr; 30(4):552-62. PubMed ID: 12722807
[TBL] [Abstract][Full Text] [Related]
5. A new method of incorporating systematic uncertainties in intensity-modulated radiotherapy optimization.
Yang J; Mageras GS; Spirou SV; Jackson A; Yorke E; Ling CC; Chui CS
Med Phys; 2005 Aug; 32(8):2567-79. PubMed ID: 16193787
[TBL] [Abstract][Full Text] [Related]
6. EUD-based margin selection in the presence of set-up uncertainties.
Song W; Dunscombe P
Med Phys; 2004 Apr; 31(4):849-59. PubMed ID: 15125003
[TBL] [Abstract][Full Text] [Related]
7. A method of calculating a lung clinical target volume DVH for IMRT with intrafractional motion.
Kung JH; Zygmanski P; Choi N; Chen GT
Med Phys; 2003 Jun; 30(6):1103-9. PubMed ID: 12852534
[TBL] [Abstract][Full Text] [Related]
8. The effects of intra-fraction organ motion on the delivery of intensity-modulated field with a multileaf collimator.
Chui CS; Yorke E; Hong L
Med Phys; 2003 Jul; 30(7):1736-46. PubMed ID: 12906191
[TBL] [Abstract][Full Text] [Related]
9. Online image-guided intensity-modulated radiotherapy for prostate cancer: How much improvement can we expect? A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery.
Ghilezan M; Yan D; Liang J; Jaffray D; Wong J; Martinez A
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1602-10. PubMed ID: 15590192
[TBL] [Abstract][Full Text] [Related]
10. A numerical simulation of organ motion and daily setup uncertainties: implications for radiation therapy.
Killoran JH; Kooy HM; Gladstone DJ; Welte FJ; Beard CJ
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(1):213-21. PubMed ID: 9054898
[TBL] [Abstract][Full Text] [Related]
11. Coverage optimized planning: probabilistic treatment planning based on dose coverage histogram criteria.
Gordon JJ; Sayah N; Weiss E; Siebers JV
Med Phys; 2010 Feb; 37(2):550-63. PubMed ID: 20229863
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric comparison of intensity-modulated, conformal, and four-field pelvic radiotherapy boost plans for gynecologic cancer: a retrospective planning study.
Chan P; Yeo I; Perkins G; Fyles A; Milosevic M
Radiat Oncol; 2006 May; 1():13. PubMed ID: 16722546
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of clinical margins via simulation of patient setup errors in prostate IMRT treatment plans.
Gordon JJ; Crimaldi AJ; Hagan M; Moore J; Siebers JV
Med Phys; 2007 Jan; 34(1):202-14. PubMed ID: 17278506
[TBL] [Abstract][Full Text] [Related]
14. IMRT to escalate the dose to the prostate while treating the pelvic nodes.
Cavey ML; Bayouth JE; Colman M; Endres EJ; Sanguineti G
Strahlenther Onkol; 2005 Jul; 181(7):431-41. PubMed ID: 15995836
[TBL] [Abstract][Full Text] [Related]
15. Methods for monitor-unit-preserving adaptation of intensity modulated arc therapy techniques to the daily target-A simple comparison.
Bratengeier K; Oechsner M; Gainey M
Med Phys; 2012 Feb; 39(2):713-20. PubMed ID: 22320781
[TBL] [Abstract][Full Text] [Related]
16. Prostate and seminal vesicle volume based consideration of prostate cancer patients for treatment with 3D-conformal or intensity-modulated radiation therapy.
Reddy NM; Nori D; Chang H; Lange CS; Ravi A
Med Phys; 2010 Jul; 37(7):3791-801. PubMed ID: 20831087
[TBL] [Abstract][Full Text] [Related]
17. Loss of local control due to tumor displacement as a function of margin size, dose-response slope, and number of fractions.
Selvaraj J; Uzan J; Baker C; Nahum A
Med Phys; 2013 Apr; 40(4):041715. PubMed ID: 23556885
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric influences of rotational setup errors on head and neck carcinoma intensity-modulated radiation therapy treatments.
Fu W; Yang Y; Yue NJ; Heron DE; Saiful Huq M
Med Dosim; 2013; 38(2):125-32. PubMed ID: 23266161
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric implications of residual seminal vesicle motion in fiducial-guided intensity-modulated radiotherapy for prostate cancer.
Stenmark MH; Vineberg K; Ten Haken RK; Hamstra DA; Feng M
Med Dosim; 2012; 37(3):240-4. PubMed ID: 22189029
[TBL] [Abstract][Full Text] [Related]
20. Technical note: calculation of normal tissue complication probability using Gaussian error function model.
Chow JC; Markel D; Jiang R
Med Phys; 2010 Sep; 37(9):4924-9. PubMed ID: 20964211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
